Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q2 2021 Results – Earnings Call Transcript
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q2 2021 Results Earnings Conference Call August 5, 2021 5:00 PM ETCompany ParticipantsRichard…
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q2 2021 Results Earnings Conference Call August 5, 2021 5:00 PM ETCompany ParticipantsRichard…
GBS Inc. is a developer of pioneering diagnostic platform adaptable to large unmet markets with multiple applications and indications….
Over the past year, Alibaba has been hit by a flood of negative news and actions from China’s regulatory…
In our yield starved world, retirees need safe sources of generous, safe and growing income to fund their golden…
Cinedigm’s successful transition has now put the company at the center of the streaming industry. Cinedigm is now delivering…
Start Time: 09:00 January 1, 0000 10:11 AM ETSampo Oyj (OTCPK:SAXPF)Q2 2021 Earnings Conference CallAugust 04, 2021, 09:00 AM…
Record market highs we are experiencing relate more to capitalization-weighted indices than strength in the average stock composing…
Eagle Bancorp (EBMT): Positive earnings momentum is likely to drive additional profitability improvement. I believe EBMT is a…
AbbVie’s diversified & strong collection of products will temper the 2023 Humira patent cliff that could decline revenues by…
Berkshire Hathaway’s 1H results were impressive with insurance underwriting better than feared and service and retail blowing…